News

NeedleSmart PRO Receives FDA Approval

Published on: 12/04/2021

NeedleSmart PRO Receives FDA Approval
Covid-19
Member News

The award-winning NeedleSmart PRO needle destruction device has achieved FDA approval as a Class II medical device.

Merseyside Based NeedleSmart Ltd is the FIRST UK company to achieve FDA 510(k) approval (Class II for Sharps Needle Destruction Device (NDD).

The innovative NeedleSmart PRO device heats a sharp, contaminated hypodermic needle to 1,300, then compresses the molten metal into a smooth ball at the end of the syringe, removing the danger of needlestick injury and infection in just 6 seconds.

NeedleSmart’s patented technology is engineered in the UK, with offices in Knowsley, Merseyside (UK), and recently opened Pittsburgh, Pennsylvania (USA).

The NeedleSmart PRO will be used in clinical environments including hospitals and GP surgeries, and will be used in digital vaccination programmes and immunisations based in the North West.

The device offers many benefits

  • Reduction of needlestick injuries (NSI) and associated costs both emotional and financial.
  • Sustainability approx. 25% reduction in sharps bin requirement, leading to less waste, and contributing to the overall carbon footprint in the medical sector.
  • Potential introduction of clinisafe bag/box as no longer a sharp.
  • Along with associated software, the device will be used to digitalise vaccination data seamlessly, securely and safely.

Merseyside based NeedleSmart CEO Cliff Kirby added: “I am absolutely thrilled that the NeedleSmart PRO has received FDA approval. Knowing we are the first UK Company to achieve this is a fantastic achievement and pays testament to the product and expertise of our team, and we are looking forward new distribution partnerships in the USA.”

NeedleSmart is a smart med-tech business focused on better health results including safety, clinical process efficiency, cost management, and digitisation of clinical events, whilst improving sustainability. FDA approval marks a milestone in NeedleSmart’s geographic expansion to serve the North American market.

For more information & images please contact:

julie@needlesmart.com

+44 (0)7850630004

T: +44 (0)151 315 0500 (UK)

T: +1 (717) 8561296 (USA)

needlesmart.com

digitalvaccination.com

NEWS​

Related News

HLTH Brought the Energy to Amsterdam. Now It’s Vegas’ Turn.

26 Jun 2025
Next up: HLTH USA, October 19–22 in Las Vegas.

From Abandonment to Belonging: Hands 4Life’s Vision for Generational Healing

26 Jun 2025
Hands 4Life is a nonprofit organization addressing the global aging crisis by empowering communities in economically developing nations—beginning with...

Strengthening Elderly Care Innovation Across Europe: ECHAlliance at the NOTRE Project Meeting in Lille

26 Jun 2025
ECHAlliance participated in the latest partner meeting of the NOTRE Project, hosted in Lille, France by our Hauts-de-France ecosystem led by Eurasanté...

Africa Health Business Co-founder Dr Amit Thakker Honoured with Top Civilian Award

26 Jun 2025
Dr. Amit N. Thakker, Co-founder of our partner Africa Health Business, receives one of the highest civilian awards from the President of Kenya.

Highlights from the Global Health Connector Partners Programme at HLTH Europe 2025

25 Jun 2025
Our Global Health Connector Partners Programme returned to HLTH Europe this June with an energising series of sessions, conversations and connections ...

That’s a Wrap from HIMSS Europe 2025!

24 Jun 2025
From Paris with purpose: Gnomon Informatics SA returned to HIMSS Europe for a third year of bold ideas, smart tech, and stronger-than-ever momentum in...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *